PARP inhibitors and prostate cancer: What urologists need to know
In this interview, Emmanuel S. Antonarakis, MD, provides an overview of rucaparib (Rubraca) and olaparib (Lynparza), discusses the key trials that led to their approvals, and explains the urologist’s role in their use.
Urologists must remain vigilant regarding post-BCG infection
"It is essential for us to be vigilant about all the complications, whether local or systemic, associated with intravesical BCG," writes Badar M. Mian, MD.
Real-time patient access to charts opens up real potential for misinterpretations
"I have no problem with patients seeing everything in their chart. It is their medical record, after all. But I do think there should be some limitations on this access," writes Henry Rosevear, MD.
Urologist claims patient negligence in defense of malpractice lawsuit
The provider said the patient failed to timely return for follow-up.
Observational study results put minimally invasive PCNL in a favorable light
Analyses of data collected in a prospectively maintained database support the recommendation for urologists to consider the minimally invasive version of mini-percutaneous nephrolithotomy for stone removal in patients with medium-sized stones (10-20 mm).
What is the status of chronic condition code G2211?
Recent legislation appears to have delayed implementation of the new code.
Do you prefer dusting or basketing when removing kidney/ureteral stones?
"Everything comes down to patient selection and location of the stones," says one urologist.
Focal radiation boost improves outcomes in prostate cancer
The boost improved biochemical disease-free survival without negatively affecting safety and quality of life.
Prostate cancer–related suicide declined over the past 20 years
The trend in prostate cancer aligns with an overall decline in cancer-related suicide across all tumor types.
ADT does not lower COVID-19 risk in men with prostate cancer
The study contradicts the findings from an Italian study published in 2020.
iTind device improves urinary function while preserving sexual function
Minimally-invasive treatment with the iTind device (Medi-Tate) provides rapid and sustained improvement of LUTS in men with BPH, without adversely affecting patients’ sexual function, according to a recently published 12-month study.
Proof of “obesity paradox” in kidney cancer continues to grow
A large review showed that cancer specific survival was improved in overweight and obese patients with renal cell carcinoma compared with patients with normal BMI.
Benefits of robotic approach to simple prostatectomy may outweigh greater cost
Compared with the open procedure, robot-assisted simple prostatectomy was associated with a shorter median hospital stay.
Study identifies optimal ureteral colic patients for early surgical intervention
Existing evidence does not clarify which patients with acute ureteral colic would benefit most from early surgical intervention.
Mirabegron may improve erectile dysfunction in men with overactive bladder symptoms
The findings support continued investigation of the safety and efficacy of mirabegron in men with OAB and concurrent ED, says study author Arthur L. Burnett, II, MD, MBA.
2 Clarke Drive Cranbury, NJ 08512